Target
Egl nine homolog 1 [181-417]
Ligand
BDBM413158
Substrate
n/a
Meas. Tech.
Inhibition Assay
IC50
3.16±n/a nM
Citation
 Brown, JWDavis, MIvetac, AJones, BKiryanov, AAKuehler, JLanier, MMiura, JMurphy, SWang, X 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD US Patent  US10407409 Publication Date 9/10/2019 
Target
Name:
Egl nine homolog 1 [181-417]
Synonyms:
C1orf12 | EGLN1 | EGLN1_HUMAN | Egl nine homolog 1 (aa 181-417)
Type:
Enzyme
Mol. Mass.:
26555.51
Organism:
Homo sapiens (Human)
Description:
aa 181-417
Residue:
237
Sequence:
PNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKP
  
Inhibitor
Name:
BDBM413158
Synonyms:
(S)-4-(1-(5-(3,4-dimethylpiperazine-1-carbonyl)pyridin-2-yl)-5-hydroxy-1H-pyrazol-4-yl)-2-fluoro-5-methylbenzonitrile | US10407409, Example 400
Type:
Small organic molecule
Emp. Form.:
C23H23FN6O2
Mol. Mass.:
434.4661
SMILES:
C[C@H]1CN(CCN1C)C(=O)c1ccc(nc1)-n1ncc(c1O)-c1cc(F)c(cc1C)C#N |r|
Structure:
Search PDB for entries with ligand similarity: